Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05257473 · ClinicalTrials.gov registry record
Defining Endpoints in Becker Muscular Dystrophy
A clinical trial of Becker Muscular Dystrophy and Muscular Dystrophies, sponsored by Virginia Commonwealth University.
- Active
- Registry status
- 80
- Enrollment target
- 11
- Study locations
NCT05257473 is a study of Becker Muscular Dystrophy and Muscular Dystrophies that is active but no longer recruiting, run by Virginia Commonwealth University. The registered enrollment target is 80 participants, below the 1,389-participant average among 12 other Becker Muscular Dystrophy trials with a reported enrollment target (94% lower). The trial reports 11 study locations across 10 states.
The verdict
NCT05257473, a study of Becker Muscular Dystrophy and Muscular Dystrophies, is active but no longer recruiting, sponsored by Virginia Commonwealth University.
- ACTIVE NOT RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 11
- Study locations
Study Summary
This is a 24-month, observational study of 50 participants with Becker muscular dystrophy (BMD)
Conditions Studied
Study Locations (11)
Other
- University of Auckland - Auckland
- John Walton Muscular Dystrophy Research Centre - Newcastle upon Tyne
California
- University of California, Irvine - Orange
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Iowa
- University of Iowa - Iowa City
Kansas
- University of Kansas Medical Center - Kansas City
Maryland
- Kennedy Krieger Institute - Baltimore
Minnesota
- University of Minnesota - Minneapolis
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-04-13 |
| Est. Completion | 2026-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05257473
The ClinicalTrials.gov registry entry for NCT05257473 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,389-participant average among 12 other Becker Muscular Dystrophy trials with a reported enrollment target (94% lower). The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Becker Muscular Dystrophy appearing as the primary indexed condition, and to 0 interventions.
NCT05257473 reports 11 study locations spanning 10 distinct geographic areas - top geographies include Other, California, Colorado.
Frequently Asked Questions
What is clinical trial NCT05257473 about?
NCT05257473 is a clinical study titled "Defining Endpoints in Becker Muscular Dystrophy". This is a 24-month, observational study of 50 participants with Becker muscular dystrophy (BMD)
What is the current status of trial NCT05257473?
This trial is currently active not recruiting. The enrollment target is 80 participants. The study started on 2022-04-13. Estimated completion is 2026-05.
What conditions does trial NCT05257473 study?
This clinical trial studies the following conditions: Becker Muscular Dystrophy, Muscular Dystrophies, Muscular Dystrophy in Children, Muscular Dystrophy, Becker.
Who is sponsoring clinical trial NCT05257473?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05257473 being conducted?
This trial has 11 study locations across California, Colorado, Iowa, Kansas, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Becker Muscular Dystrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Duchenne Registry
RECRUITING
-
Biomarker Development for Muscular Dystrophies
RECRUITING
-
Magnetic Resonance Imaging and Biomarkers for Muscular Dystrophy
RECRUITING
-
CureDuchenne Link®: A Resource for Research
RECRUITING
-
Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD
ACTIVE NOT RECRUITING
-
Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)
ACTIVE NOT RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.